Cancer Research UK logo.
SearchDonate
  • Search

A trial of enadenotucirev for ovarian cancer (OCTAVE)

Overview

Cancer types:

Ovarian cancer

Status:

Results

Phase:

Phase 1

Details

This trial was for women with ovarian cancer that had got worse after having

It was for women who had 1 of the following:

  • ovarian cancer

  • primary peritoneal cancer

  • fallopian tube cancer

Doctors treat these cancers in the same way. When we use the term ovarian cancer in this summary we are referring to all of these.

This trial was open for women to join between 2014 and 2018. The team published the results in 2021.

Recruitment start: 2 June 2014

Recruitment end: 17 December 2018

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Professor Iain McNeish

Supported by

Akamis Bio Ltd

NIHR Clinical Research Network: Cancer

Last reviewed: 23 Apr 2023

CRUK internal database number: 11596

The Dangoor Education logo.

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Patient Information Forum. Trusted Information Creator.
Plain English Campaign award.

Help and support

An icon of a hand shake.

Questions for your doctor

What to ask your doctor about clinical trials.

An icon of two speech bubbles, indicating a conversation.

Cancer chat forum

Meet and chat to other cancer people affected by cancer.

An icon of a landline phone.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.